Osteoarthritis (OA) is a leading cause of chronic pain and disability, for which there is no
cure. Mesenchymal stromal cells (MSCs) have been used in clinical trials for treating OA due …

Osteoarthritis (OA) is a degenerative multifactorial disease with concomitant structural,
inflammatory, and metabolic changes that fluctuate in a temporal and patient-specific …

Osteoarthritis (OA) is a degenerative joint disease that affects cartilage, subchondral bone,
the synovium and synovial fluid and has limited treatment options. With an ageing …

Patients with late-stage Kellgren-Lawrence knee osteoarthritis received a single intra-
articular injection of 1, 10, or 50 million bone marrow mesenchymal stromal cells (BM-MSCs) …

Recently, intra-articular injections of mesenchymal stem cells (MSCs) have been used as a
treatment for early osteoarthritis (OA) due to the known immunomodulatory effects of these …

Recently, mesenchymal stem/stromal cells (MSCs) transplantation has been introduced as a
promising option to support cartilage structure and improve its function in preclinical models …

Evidence from completed preclinical and clinical studies conducted worldwide suggests that
mesenchymal stromal cells (MSCs) are a novel and promising option for the treatment of …

Literature review of MSCs in the treatment of osteoarthritis in the past five years
Osteoarthritis (OA) is one of the most common chronic joint diseases, with prominent …

OA is a complex and highly prevalent degenerative disease affecting the whole joint, in
which factors like genetic predisposition, gender, age, obesity and traumas contribute to joint …

Osteoarthritis (OA) is a common progressively degenerative joint disease that affects more
than 300 million people worldwide. OA is manifested by articular cartilage degradation …